Agnieszka Kołkowska‐Leśniak

Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors

Anna Rychter, Piotr Jerzmanowski, Adam Hołub et al. · Medical Oncology · 2017 · 42 citations · Full text

Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment

Joanna Góra‐Tybor, Ewa Mędraś, Małgorzata Całbecka et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 40 citations

Mixed-phenotype Acute Leukemia, Pathology, Pharmacotherapy +17

Outcomes of treatment with dose‐adjusted EPOCH‐R or R‐CHOP in primary mediastinal large B‐cell lymphoma

Agata Malenda, Agnieszka Kołkowska‐Leśniak, Bartosz Puła et al. · European Journal Of Haematology · 2019 · 37 citations · Full text

Surgical Oncology, Pathology, Surgery +16

SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism

Anna Polak, Emilia Białopiotrowicz, Beata Krzymieniewska et al. · Cell Death and Disease · 2020 · 37 citations · Full text

Demographic, Hematologic, and Clinical Features of Myelodysplastic Syndrome Patients: Results from the First Polish Myelodysplastic Syndrome Registry

Krzysztof Mądry, Rafał Machowicz, Anna Waszczuk‐Gajda et al. · Acta Haematologica · 2015 · 11 citations